NCT00236600View on ClinicalTrials.gov

A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

PHASE3CompletedINTERVENTIONAL
Enrollment

561

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

June 30, 2002

Conditions
Obesity
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236600 - A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program | Biotech Hunter | Biotech Hunter